BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36517649)

  • 1. Follow, consider, and catch: second primary tumors in acromegaly patients.
    Oguz SH; Firlatan B; Sendur SN; Dagdelen S; Erbas T
    Endocrine; 2023 Apr; 80(1):160-173. PubMed ID: 36517649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer.
    Ruchala M; Skiba A; Gurgul E; Uruski P; Wasko R; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(3):382-6. PubMed ID: 19855364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.
    Gasperi M; Martino E; Manetti L; Arosio M; Porretti S; Faglia G; Mariotti S; Colao AM; Lombardi G; Baldelli R; Camanni F; Liuzzi A;
    J Endocrinol Invest; 2002 Mar; 25(3):240-5. PubMed ID: 11936466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of differentiated thyroid carcinoma in acromegaly.
    Tita P; Ambrosio MR; Scollo C; Carta A; Gangemi P; Bondanelli M; Vigneri R; degli Uberti EC; Pezzino V
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):161-7. PubMed ID: 16060909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors of cancers in acromegaly: a Chinese single-center retrospective study.
    Xiao T; Jiao R; Yang S; Wang Y; Bai X; Zhou J; Li R; Wang L; Yang H; Yao Y; Deng K; Gong F; Pan H; Duan L; Zhu H
    Endocrine; 2023 Nov; 82(2):368-378. PubMed ID: 37442901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients.
    Dogan S; Atmaca A; Dagdelen S; Erbas B; Erbas T
    Endocrine; 2014 Feb; 45(1):114-21. PubMed ID: 23670709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease Activity May Not Affect the Prognosis of Coexisting Thyroid Cancer in Acromegalic Patients.
    Gul N; Soyluk O; Dogansen SC; Kurtulmus N; Yarman S
    Exp Clin Endocrinol Diabetes; 2020 Sep; 128(9):567-572. PubMed ID: 31185505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and treatment outcomes of micromegaly - acromegaly with apparently normal basal GH: A retrospective study and literature review.
    Inacio I; Fonseca L; Amado A; Benido V; Ribeiro I; Dores J; Amaral C; Cardoso MH
    Endocr Regul; 2022 Apr; 56(2):87-94. PubMed ID: 35489048
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased thyroid cancer risk in acromegaly.
    Dagdelen S; Cinar N; Erbas T
    Pituitary; 2014 Aug; 17(4):299-306. PubMed ID: 23836362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumorigenesis of papillary thyroid cancer is not BRAF-dependent in patients with acromegaly.
    Kim HK; Lee JS; Park MH; Cho JS; Yoon JH; Kim SJ; Kang HC
    PLoS One; 2014; 9(10):e110241. PubMed ID: 25329702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of thyroid disease and thyroid malignancy in acromegalic patients.
    Cankurtaran Y; Örük GG; Tozduman B
    Minerva Endocrinol (Torino); 2023 Jun; 48(2):130-139. PubMed ID: 33988006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of thyroid cancer in patients with acromegaly and non-growth hormone secreting pituitary adenomas: A prospective cross-sectional study.
    Spricido IY; Feckinghaus CM; Silva RHM; Mesa Junior CO; Boguszewski CL
    Growth Horm IGF Res; 2021 Feb; 56():101378. PubMed ID: 33486451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid cancer in patients with acromegaly: a case-control study.
    dos Santos MC; Nascimento GC; Nascimento AG; Carvalho VC; Lopes MH; Montenegro R; Montenegro R; Vilar L; Albano MF; Alves AR; Parente CV; dos Santos Faria M
    Pituitary; 2013 Mar; 16(1):109-14. PubMed ID: 22527615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Experience of a Single Tertiary Center Regarding Benign and Malignant Tumors in Acromegalic Patients.
    Plotuna IS; Balas M; Golu I; Amzar D; Vlad A; Moleriu LC; Vlad M
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374352
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acromegaly and thyroid disease: prevalence of thyroid cancer].
    Marchisotti FG; Umeda LM; Zach PL; Saldanha MD; First OS; Liberman B
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):843-9. PubMed ID: 16444369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of small bowel tumors by videocapsule endoscopy in patients with acromegaly.
    Ronchi CL; Coletti F; Fesce E; Montefusco L; Ogliari C; Verrua E; Epaminonda P; Ferrante E; Malchiodi E; Morelli V; Beck-Peccoz P; Arosio M
    J Endocrinol Invest; 2009 Jun; 32(6):495-500. PubMed ID: 19494714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid cancer is the most common cancer associated with acromegaly.
    Gullu BE; Celik O; Gazioglu N; Kadioglu P
    Pituitary; 2010 Sep; 13(3):242-8. PubMed ID: 20217483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of thyroid diseases in patients with acromegaly: experience of a Brazilian center.
    Uchoa HB; Lima GA; Corrêa LL; Vidal AP; Cavallieri SA; Vaisman M; Buescu A; Gadelha MR
    Arq Bras Endocrinol Metabol; 2013 Dec; 57(9):685-90. PubMed ID: 24402013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and hormonal findings in patients presenting with high IGF-1 and growth hormone suppression after oral glucose load: a retrospective cohort study.
    Carosi G; Mangone A; Sala E; Del Sindaco G; Mungari R; Cremaschi A; Ferrante E; Arosio M; Mantovani G
    Eur J Endocrinol; 2021 Jul; 185(2):289-297. PubMed ID: 34081617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac effect of thyrotoxicosis in acromegaly.
    Marzullo P; Cuocolo A; Ferone D; Pivonello R; Salvatore M; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.